RENOVARO INC (RENB) Stock Price, Quote, News and Overview
NASDAQ:RENB - Nasdaq - US29350E1047 - Common Stock - Currency: USD
RENB Quote, Performance and Key Statistics
0.3732
+0 (+0.11%)
The current stock price of RENB is 0.3732 USD. In the past month the price decreased by -42.54%. In the past year, price decreased by -75.61%.
RENB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.39 | 329.14B | ||
| AMGN | AMGEN INC | 14.17 | 150.99B | ||
| GILD | GILEAD SCIENCES INC | 13.33 | 128.61B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1702.9 | 126.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 65.88B | ||
| ARGX | ARGENX SE - ADR | 330.52 | 37.54B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.72B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.39B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.52B | ||
| NTRA | NATERA INC | N/A | 20.79B | ||
| BIIB | BIOGEN INC | 7.22 | 17.39B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.30B |
Related stock screener links
About RENB
Company Profile
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 25 full-time employees. The company went IPO on 2014-11-18. The firm operates through two subsidiaries: Renovaro Biosciences, Inc. (Renovaro Biosciences) and Renovaro Cube. Renovaro Biosciences is a biotechnology company intending to develop advanced allogeneic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as Human Immunodeficiency Virus (HIV) infections. Renovaro Cube is an AI-driven healthcare technology company focusing on the earliest possible detection of cancer and its recurrence. Renovaro Cube has developed an AI platform that analyzes genetics using Explainable AI to provide earlier and more accurate cancer diagnosis. This platform uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients.
Company Info
RENOVARO INC
Century City Medical Plaza, 2080 Century City East, Suite 906
Los Angeles CALIFORNIA US
Employees: 12
Company Website: https://renovarobio.com/
Investor Relations: http://www.enochianbio.com/investors-media/stock-info/
Phone: 14539179840
RENOVARO INC / RENB FAQ
What is the stock price of RENOVARO INC today?
The current stock price of RENB is 0.3732 USD. The price increased by 0.11% in the last trading session.
What is the ticker symbol for RENOVARO INC stock?
The exchange symbol of RENOVARO INC is RENB and it is listed on the Nasdaq exchange.
On which exchange is RENB stock listed?
RENB stock is listed on the Nasdaq exchange.
What is RENOVARO INC worth?
RENOVARO INC (RENB) has a market capitalization of 66.20M USD. This makes RENB a Micro Cap stock.
How many employees does RENOVARO INC have?
RENOVARO INC (RENB) currently has 12 employees.
What are the support and resistance levels for RENOVARO INC (RENB) stock?
RENOVARO INC (RENB) has a resistance level at 0.4. Check the full technical report for a detailed analysis of RENB support and resistance levels.
Should I buy RENOVARO INC (RENB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RENB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RENB, evaluating the profitability, health, valuation and growth aspects
- RENOVARO INC (RENB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RENOVARO INC (RENB) Sales and EPS estimates to see what analysts future expectations are.
- RENOVARO INC (RENB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RENOVARO INC (RENB) Insider and Institutional Ownership to learn about the owners and their transactions.
- RENOVARO INC (RENB) Stock Chart to make your own analysis
- RENOVARO INC (RENB) Latest news and press-releases to stay up to date.
Does RENOVARO INC (RENB) stock pay dividends?
RENB does not pay a dividend.
When does RENOVARO INC (RENB) report earnings?
RENOVARO INC (RENB) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of RENOVARO INC (RENB)?
RENOVARO INC (RENB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.91).
What is the Short Interest ratio of RENOVARO INC (RENB) stock?
The outstanding short interest for RENOVARO INC (RENB) is 5.65% of its float. Check the ownership tab for more information on the RENB short interest.
RENB Technical Analysis
RENB Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RENB. RENB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
RENB Financial Highlights
Over the last trailing twelve months RENB reported a non-GAAP Earnings per Share(EPS) of -0.91. The EPS decreased by -32.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -106.35% | ||
| ROE | -144.3% | ||
| Debt/Equity | 0 |